Researches on PEG-modified copolymer nanoparticle.
- Author:
Wei CHEN
1
;
Xiangliang YANG
Author Information
1. Pharmaceutical Institute, Hua Zhong University of Science and Technology, Wuhan 430074.
- Publication Type:Journal Article
- MeSH:
Animals;
Drug Carriers;
pharmacokinetics;
Drug Compounding;
methods;
Drug Delivery Systems;
In Vitro Techniques;
Nanotechnology;
Polyethylene Glycols;
chemical synthesis;
chemistry;
Polymers;
chemical synthesis;
chemistry
- From:
Journal of Biomedical Engineering
2003;20(1):143-147
- CountryChina
- Language:Chinese
-
Abstract:
Biodegradable polymeric nanoparticles acting as drug carrier have important potential applications such as site-specific drug delivery and controllable drug delivery. However, these carriers cannot generally be used because they are eliminated by the reticulo-endothelial system within seconds or minutes after intravenous injection. To overcome this limitation, more and more researchers introduce hydrophilic polyethylene glyeol(PEG) to modify polymeric nanoparticles for avoiding their uptake by reticulo-endothelial system. Introducing PEG not only changes polymer nanoparticles' biodegradation in vivo, but also influences drug's properties such as drug release, in vivo biodistribution, et. al. In this paper are reviewed the researches of PEG-modified copolymer nanoparticles, including their preparation and size distribution, stability, drug incorporation, drug release, in vivo biodistribution, in vitro cytotoxicty. A prospect for the researches and developments of the PEG-modified copolymer nanoparticles was also made.
